Indian Journal of Pharmacy and Pharmacology

Print ISSN: 2393-9079

Online ISSN: 2393-9087

CODEN : IJPPTK

Indian Journal of Pharmacy and Pharmacology (IJPP) open access, peer-reviewed quarterly journal publishing since 2014 and is published under auspices of the Innovative Education and Scientific Research Foundation (IESRF), aim to uplift researchers, scholars, academicians, and professionals in all academic and scientific disciplines. IESRF is dedicated to the transfer of technology and research by publishing scientific journals, research content, providing professional’s membership, and conducting conferences, seminars, and award programs. With more...

Article type

Original Article


Article page

60-64


Authors Details

Senthilraja M*


Article Metrics


View Article As

 


Downlaod Files

   






Article statistics

Viewed: 1377

PDF Downloaded: 739


Reverse phase high performance liquid chromatography and UV-Visible method for the simultaneous estimation of gemifloxacin


Original Article

Author Details : Senthilraja M*

Volume : 6, Issue : 2, Year : 2019

Article Page : 60-64

https://doi.org/10.18231/j.ijpp.2019.014



Suggest article by email

Get Permission

Abstract

A novel UV-Visible and reversed phase High Performance Liquid Chromatography method has been developed and validated for the simultaneous analysis of gemifloxacin and their formulation. The UV-Visible method was carried with folin reagent and reverse Phase HPLC method with acetonitrile: phosphate buffer (40:60%v/v) mobile phase, having a pH of 3.0 at a wavelength of 272 nanometer. The linearity range starts from 2 to10?g/ml and 1 to 5?g/ml, percentage recovery was found to be 98.55% and 99.68%, limit of detection 0.2651?g and 0.1588?g and 0.8033?g and 0.4811?g for the UV-Visible and RP-HPLC methods respectively.

Keywords: Reversed phase-HPLC, UV-Visible, Gemifloxacin, Folin-Ciocalteu phenol reagent, Phosphate buffer.


How to cite : Senthilraja M, Reverse phase high performance liquid chromatography and UV-Visible method for the simultaneous estimation of gemifloxacin. Indian J Pharm Pharmacol 2019;6(2):60-64

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.